Deutsche Bank’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
SFCM
Deutsche Bank's ZNTL Position: Q3 2026 in Review
Deutsche Bank reduced its Zentalis Pharmaceuticals (ZNTL) stake by 12% in Q3 2026, selling an estimated $24.6K and leaving 42,709 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3310.
Deutsche Bank first reported a position in ZNTL in Q2 2020 and has held it in 22 quarters since. The position peaked at $11.8M in Q2 2023. 124 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.
- Deutsche Bank held 42,709 shares of Zentalis Pharmaceuticals worth $118K as of Q3 2026.
- Deutsche Bank sold 6,097 Zentalis Pharmaceuticals shares in Q3 2026, an estimated $24.6K.
- Zentalis Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3310 holding.
- Deutsche Bank first reported a position in Zentalis Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
- Deutsche Bank's Zentalis Pharmaceuticals position peaked at $11.8M in Q2 2023.
- 124 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.